News | May 06, 2024
Zydus Wellness launches pilot for ready-to-drink beverage Glucon-D Activors
The brand has also unveiled a new TVC campaign in Telangana and Andhra Pradesh to drive brand awareness
The brand has also unveiled a new TVC campaign in Telangana and Andhra Pradesh to drive brand awareness
If approved, the Opdivo-based regimen would be the first immunotherapy-chemotherapy combination approved for this patient population in the EU
Syngene International has reported total income of Rs. 933 crores during the period ended March 31, 2024
The company will closely work with the USFDA to address and respond to the observations in an expeditious manner
This approval helps address an urgent unmet need, with about half of people living with early-stage NSCLC experiencing disease recurrence following surgery, despite adjuvant chemotherapy
NexGard Spectra is a soft, flavourful monthly chew that kills fleas before they can lay eggs
The US Generics market has been witnessing significant pricing pressure leading to significant losses at Jubilant Cadista since FY2022 onwards.
Around 7% of the Indian population suffers from IBS
FDA has concluded that this inspection is 'closed'
Interim analysis of an ongoing 156-week extension study supports long-term safety, tolerability and efficacy of atogepant 60 mg to prevent chronic and episodic migraine
Subscribe To Our Newsletter & Stay Updated
